Clayton Wood House
6 Clayton Wood Bank
Leeds LS16 6QZ
United Kingdom
44 11 3230 7597
https://www.sigroupplc.com
Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees:
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. David John Marsh | CEO & Director | 211k | N/A | 1964 |
Mr. Alex Hogg | Operations Director | N/A | N/A | N/A |
Mr. Stephen Seed | Chief Compliance Officer | N/A | N/A | N/A |
Mr. Damian Donnelly | Chief Commercial Officer | N/A | N/A | N/A |
Surgical Innovations Group plc, together with its subsidiaries, designs, develops, manufactures, and sells devices for use in minimally invasive surgery and precision engineering markets in the United Kingdom, Europe, the Asia Pacific, the United States, and internationally. It operates through three segments: SI Brand, Original Equipment Manufacturer (OEM), and Distribution. The company offers YelloPort Elite and YelloPort +plus port access systems; PretzelFlex, a surgical retracting system; FastClamp, an endoscopic clamping system; LogiCut, a disposable laparoscopic insert; Logic, a reusable laparoscopic instrument; and LogiFlex, an articulating dissector and retractor. It also researches, develops, manufactures, and distributes minimally invasive devices for third party medical device companies through own label or co-branding; minimally invasive technology products for precision engineering applications; and services for design and build of instruments. In addition, the company distributes medical products; and designs and manufactures autologous blood products. It sells its products through independent healthcare distributors, as well as its own label products through OEM relationships. Surgical Innovations Group plc was incorporated in 1988 and is based in Leeds, the United Kingdom.
Surgical Innovations Group plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.